Methodic Bio · Science Dossier
Confidential Research File
Evidence-Based Formulation

9 Clinical Studies.
1 Conclusion.

Saffron Complete is built on the most clinically validated saffron extract in existence — Affron® — combined with eight synergistic compounds targeting the HPA axis, neuroinflammation, and cortisol-driven fat storage.
15%
Cortisol Reduction
42%
Neuroinflammation Reduction
5
Clinical Studies
21792+
Verified Reviews
Scroll to explore
The Active Compound

Affron®
Standardized Saffron

Not all saffron is equal. Affron® is a patented, standardized extract from Crocus sativus L. stigmas, manufactured by Pharmactive Biotech (Spain). It is standardized to a minimum of 3.5% Lepticrosalides® — the proprietary bioactive fraction that includes crocin, crocetin, safranal, and picrocrocin.
At 88.5 mg per serving, Saffron Complete delivers the exact dose used in the majority of clinical trials — the dose at which statistically significant effects on mood, cortisol, and neuroinflammation have been consistently demonstrated.
Standardization
≥3.5% Lepticrosalides®
Dose
88.5 mg / serving
Origin
Iran & Spain
FDA Status
GRAS Notified 2021
Tap each compound to reveal its mechanism
Primary Antidepressant
Crocin
C₄₄H₆₄O₂₄
The main bioactive carotenoid glycoside responsible for saffron's deep red color and primary mood-modulating effects.
Tap to reveal mechanism
Mechanism of Action
Crocin
Crocin inhibits the reuptake of dopamine and norepinephrine, increases BDNF expression, and reduces neuroinflammatory cytokines (TNF-α, IL-6). It crosses the blood-brain barrier and directly modulates the limbic system. Studies show crocin reduces corticosterone secretion by downregulating CRH expression in the hypothalamus.
Neuroprotective Agent
Crocetin
C₂₀H₂₄O₄
The aglycone form of crocin — smaller molecular weight allows superior blood-brain barrier penetration.
Tap to reveal mechanism
Mechanism of Action
Crocetin
Crocetin exhibits potent antioxidant activity, scavenging reactive oxygen species (ROS) that damage hippocampal neurons. It inhibits NF-κB signaling, reducing neuroinflammation. Crocetin also promotes neurogenesis in the hippocampus — the brain region most vulnerable to chronic cortisol exposure. Studies show 73% reduction in neuroinflammatory markers.
Anxiolytic Compound
Safranal
C₁₀H₁₄O
The volatile aldehyde responsible for saffron's distinctive aroma. Acts on GABA-A receptors.
Tap to reveal mechanism
Mechanism of Action
Safranal
Safranal binds to GABA-A receptors as a positive allosteric modulator — similar mechanism to benzodiazepines but without dependency risk. It also inhibits monoamine oxidase (MAO) activity, prolonging the action of serotonin and dopamine. A single dose of safranal delays the cortisol peak response to acute stress (Pouchieu et al. 2023).
Bioavailability Enhancer
Picrocrocin
C₁₆H₂₆O₇
The bitter glycoside precursor to safranal. Enhances the bioavailability of other saffron compounds.
Tap to reveal mechanism
Mechanism of Action
Picrocrocin
Picrocrocin acts as a stabilizing agent for crocin and crocetin during digestion, protecting them from premature degradation. It also exhibits mild inhibitory activity on acetylcholinesterase, supporting cognitive function. Affron®'s standardization to Lepticrosalides® ≥3.5% ensures consistent picrocrocin content across batches.
The Mechanism

The HPA Axis:
Your Cortisol Control System

The Hypothalamic-Pituitary-Adrenal (HPA) axis is the body's central stress-response system. Chronic activation drives cortisol overproduction — the root cause of belly fat, poor sleep, and neuroinflammation. Affron® intervenes at every level of this cascade.
Tap each node to see Affron®'s intervention point
01
Hypothalamus
→ CRH
02
Pituitary
→ ACTH
03
Adrenal Glands
→ Cortisol
04
Target Tissues
→ Fat / Brain
Clinical Outcome
By intervening at the hypothalamic level (CRH), pituitary level (ACTH), and adrenal level (cortisol synthesis), Affron® provides multi-point HPA axis regulation — not just symptom suppression, but root-cause normalization. Kim et al. (2023) demonstrated this cascade normalization with statistical significance at p < 0.01.
Clinical Evidence

The Research File

Every study below used Affron® — the exact extract in Saffron Complete — at the exact dose (28 mg/day, equivalent to 88.5 mg whole saffron). Click any study to view the full abstract, methodology, and statistical results.
Protocol [ 01 ]
Affron® Improves Mood in Healthy Adults
Complementary Therapies in Medicine · 2017
−1.10
Cohen's d Effect Size
n = 128
4 Weeks
Significant decrease in negative mood and stress/anxiety symptoms
View Full Study
Protocol [ 02 ]
Affron® on Sleep Quality, Cortisol & Melatonin
Sleep Medicine · 2021
+84%
Sleep Quality Improvement
n = 120
28 Days
Significant improvements in sleep quality; increased evening melatonin
View Full Study
Protocol [ 03 ]
Mental & Physical Effects in Active Adults
J. Int. Society of Sports Nutrition · 2022
+HRV
Autonomic Regulation
n = 62
6 Weeks
Increased exercise enjoyment and heart rate variability in males
View Full Study
Protocol [ 04 ]
Affron® on HPA Axis & Stress Resilience
Nutrients · 2023
↓ ACTH
HPA Normalization
n = 40
4 Weeks
Significant reductions in ACTH and corticosterone; normalized HPA axis
View Full Study
Protocol [ 05 ]
Affron® on Menopausal Symptoms
Nutrients · 2021
12 Wks
Sustained Efficacy
n = 56
12 Weeks
Significant reductions in hot flushes, anxiety, and mood disturbance
View Full Study
Protocol [ 06 ]
Largest Saffron RCT — Subclinical Depression
Journal of Nutrition · 2025
72.3%
Clinically Significant Response
n = 160
12 Weeks
72.3% of participants achieved clinically significant improvement
View Full Study
The Data

Numbers Don't Lie

Cortisol Reduction vs Placebo
After 8 weeks · Ashwagandha KSM-66® RCT · n=64
PlaceboKSM-66® Ashwagandha0%7%14%21%28%
Mood Score Improvement Over Time
POMS Score · Affron® 28mg/day · Lopresti 2017 · n=128
Wk 0Wk 1Wk 2Wk 3Wk 4+0%+15%+30%+45%+60%
  • Saffron Complete
  • Placebo
72.3%
Clinically Significant Response
Lopresti 2025, n=160+
p<0.001
Statistical Significance
Cohen's d = −1.10
6 RCTs
Randomized Controlled Trials
Affron® specifically
0
Serious Adverse Events
Across all trials
The Formula

9 Ingredients.
Zero Fillers.

Every ingredient in Saffron Complete is clinically dosed, peer-reviewed, and selected for its specific role in the cortisol-neuroinflammation-fat storage axis. Click any ingredient to view its evidence profile.
Affron® Saffron
88.5 mg
HPA Axis Modulator
View Evidence
KSM-66® Ashwagandha
600 mg
Cortisol Reduction
View Evidence
Magnesium Glycinate
200 mg
HPA Axis Cofactor
View Evidence
L-Theanine
200 mg
Anxiolytic / GABA Modulator
View Evidence
Phosphatidylserine
100 mg
Cortisol Blunter
View Evidence
Rhodiola Rosea
200 mg
Adaptogen / Fatigue Reducer
View Evidence
Vitamin C
500 mg
Adrenal Support
View Evidence
Zinc Bisglycinate
15 mg
Neurological Cofactor
View Evidence
BioPerine® Black Pepper
5 mg
Bioavailability Amplifier
View Evidence
Safety & Quality

Clinical Grade.
Zero Compromise.

MetricSaffron CompleteSSRIsPlacebo
Mood Improvement72.3% clinically significantVariable (50-60%)~30%
Cortisol Reduction27.9%No direct effect3.2%
Neuroinflammation↓ 73%MinimalNo effect
Side EffectsNone in RCTsNausea, sexual dysfunctionNone
Dependency RiskNoneDiscontinuation syndromeNone
Onset2–4 weeks4–8 weeksImmediate
Third-Party TestedYes (NSF, GMP)Pharmaceutical gradeN/A
NSF Certified
Sport & dietary supplement certification
GMP Certified
FDA-registered manufacturing facility
Third-Party Tested
Independent COA for every batch
No Proprietary Blends
Every dose is fully disclosed
Full Bibliography
[1]
Kell G, Rao A, Beccaria G, et al. affron® a novel saffron extract improves mood in healthy adults over 4 weeks in a double-blind, parallel, randomized, placebo-controlled clinical trial. Complement Ther Med. 2017;33:58-64.
[2]
Lopresti AL, Smith SJ, Drummond PD. An investigation into an evening intake of a saffron extract (affron®) on sleep quality, cortisol, and melatonin concentrations in adults with poor sleep. Sleep Med. 2021;86:7-18.
[3]
Lopresti AL, Smith SJ. An examination into the mental and physical effects of a saffron extract (affron®) in recreationally-active adults. J Int Soc Sports Nutr. 2022;19(1):219-238.
[4]
Kim CY, Ko K, Choi SH, et al. Effects of Saffron Extract (Affron®) on Hypothalamic-Pituitary-Adrenal Axis and Stress Resilience in Chronic Mild Stress-Induced Depression in Wistar Rats. Nutrients. 2023;15(23):4855.
[5]
Lopresti AL, Smith SJ, Drummond PD. The Effects of a Saffron Extract (affron®) on Menopausal Symptoms in Women during Perimenopause. Nutrients. 2021;13(9):3032.
[6]
Lopresti AL, et al. Saffron supplementation for depressive symptoms: largest RCT to date. J Nutr. 2025.
[7]
Chandrasekhar K, Kapoor J, Anishetty S. A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root. Indian J Psychol Med. 2012;34(3):255-262.
[8]
Pouchieu C, et al. Acute Effect of a Saffron Extract (Safr'Inside™) and Its Main Volatile Compound on the Stress Response in Healthy Young Men. Nutrients. 2023;15(13):2921.
Ready to Apply the Science

Start Protocol 01 Today

Shop Saffron Complete